Metagenomi Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $324.6M
Liabilities Breakdown FY2024
Total Liabilities: $89.7M
Asset Breakdown
Total Assets: $324.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $27.4M | 8.4% |
| Accounts Receivable | $1.3M | 0.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $17.7M | 5.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $278.2M | 85.7% |
Liabilities Breakdown
Total Liabilities: $89.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $533.0K | 0.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $89.2M | 99.4% |